{
  "paper": "8b5cbac7e6bc0d81d286e5b3b0fd6460.txt",
  "words": 11898,
  "extractions": {
    "title": {
      "value": "Population Genomics Approaches for Genetic Characterization of SARS-CoV-2 Lineages",
      "justification": "The title is directly mentioned at the beginning of the paper as \"Population Genomics Approaches for Genetic Characterization of SARS-CoV-2 Lineages.\"",
      "quote": "Mostefai F, Gamache I, N’Guessan A, Pelletier J, Huang J, Murall CL, Pesaranghader A, Gaonac’h-Lovejoy V, Hamelin DJ, Poujol R, Grenier J-C, Smith M, Caron E, Craig M, Wolf G, Krishnaswamy S, Shapiro BJ, and Hussin JG (2022) Population Genomics Approaches for Genetic Characterization of SARS-CoV-2 Lineages. Front. Med. 9:826746."
    },
    "description": "The paper presents a computational framework using population genomics approaches to better understand the genetic diversity and evolution of SARS-CoV-2 lineages during the first year of the COVID-19 pandemic. It utilizes genomic surveillance tools to analyze and evaluate the genetic diversity and lineage trajectories using data from the GISAID database.",
    "type": {
      "value": "empirical",
      "justification": "The study conducts an analysis of genetic diversity using real-world genomic data collected from the GISAID database. It performs various computational experiments such as haplotype network generation, allele frequency trajectory analysis, and principal component analysis using empirical data.",
      "quote": "We analyzed 329,854 high-quality consensus sequences published in the GISAID database during the pre-vaccination phase."
    },
    "primary_research_field": {
      "name": {
        "value": "Genomics",
        "justification": "The research focuses on using genomic data to understand the genetic diversity and evolution of SARS-CoV-2 lineages, which is a core aspect of genomics.",
        "quote": "We present here a set of genomic surveillance tools from population genetics which can be used to better understand the evolution of this virus in humans."
      },
      "aliases": [
        "Population Genomics"
      ]
    },
    "sub_research_fields": [
      {
        "name": {
          "value": "Bioinformatics",
          "justification": "The study employs computational methods, including haplotype networks, PCA, and allele frequency calculation, to analyze genomic data, which is a bioinformatics-based approach.",
          "quote": "This computational framework can help design efficient preventive strategies, identify potentially expanding, divergent lineages and derive a fast response against viral adaptation to future therapeutic strategies."
        },
        "aliases": []
      },
      {
        "name": {
          "value": "Infectious Diseases",
          "justification": "The context of the study revolves around understanding the spread and evolution of the SARS-CoV-2 virus, which directly relates to the field of infectious diseases.",
          "quote": "This article was submitted to Infectious Diseases - Surveillance, Prevention and Treatment."
        },
        "aliases": []
      }
    ],
    "models": [
      {
        "name": {
          "value": "ImputeCoVNet",
          "justification": "ImputeCoVNet is explicitly mentioned as a model used for sequence imputation to reduce missing data in the genomic sequences.",
          "quote": "To help reduce this missing data problem and improve variant assignment, we next imputed all sequences using ImputeCoVNet (17) at positions where the derived allele frequency (DAF) was over 1% during at least one month."
        },
        "aliases": [],
        "is_contributed": {
          "value": false,
          "justification": "The paper uses ImputeCoVNet, which is already existing model for imputation and not a new contribution by this paper.",
          "quote": "We next imputed all sequences using ImputeCoVNet (17) at positions where the derived allele frequency (DAF) was over 1% during at least one month (199 positions)."
        },
        "is_executed": {
          "value": false,
          "justification": "The paper does not mention the specifics of execution regarding GPU or CPU while describing ImputeCoVNet, focusing more on the application and results instead.",
          "quote": "This novel approach uses a 2D residual neural-network autoencoder that has an accuracy of > 99% and surpasses distance-based methods in terms of computation time (17)."
        },
        "is_compared": {
          "value": false,
          "justification": "The paper does not conduct a numerical comparison of ImputeCoVNet with other models; it simply uses it for processing and analysis without exploring further comparative analysis in terms of performance metrics.",
          "quote": "This novel approach uses a 2D residual neural-network autoencoder that has an accuracy of > 99% and surpasses distance-based methods in terms of computation time (17)."
        },
        "referenced_paper_title": {
          "value": "ImputeCoVNet: 2D ResNet autoencoder for imputation of SARS-CoV-2 sequences",
          "justification": "The reference title of the paper for ImputeCoVNet is given as \"ImputeCoVNet: 2D ResNet autoencoder for imputation of SARS-CoV-2 sequences.\"",
          "quote": "Pesaranghader A, Pelletier J, Grenier JC, Poujol R, Hussin J. ImputeCoVNet: 2D ResNet autoencoder for imputation of SARS-CoV-2 sequences. bioRxiv [Preprint]. (2021)."
        }
      }
    ],
    "datasets": [
      {
        "name": {
          "value": "GISAID",
          "justification": "The GISAID database is repeatedly mentioned as the primary source of genomic sequences analyzed in the study.",
          "quote": "We analyzed 329,854 high-quality consensus sequences published in the GISAID database during the pre-vaccination phase."
        },
        "aliases": [],
        "role": "used",
        "referenced_paper_title": {
          "value": "Data, disease and diplomacy: GISAID’s innovative contribution to global health",
          "justification": "This title is referenced to highlight GISAID's contribution to global health, as mentioned in the acknowledgments for their data usage.",
          "quote": "Elbe S, Buckland-Merrett G. Data, disease and diplomacy: GISAID’s innovative contribution to global health. Glob Chall. (2017) 1:33–46. doi: 10.1002/gch2.1018"
        }
      }
    ],
    "libraries": []
  },
  "usage": {
    "completion_tokens": 1230,
    "prompt_tokens": 21471,
    "total_tokens": 22701,
    "completion_tokens_details": {
      "accepted_prediction_tokens": null,
      "audio_tokens": 0,
      "reasoning_tokens": 0,
      "rejected_prediction_tokens": null
    },
    "prompt_tokens_details": {
      "audio_tokens": 0,
      "cached_tokens": 0
    }
  }
}